Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Hosts 11th Annual Neuroscience Online Event Scheduled on March 8, 2023
  • USA - English


News provided by

Labroots

Mar 02, 2023, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Neuroscience Virtual Event Series, March 8, 2023
Neuroscience Virtual Event Series, March 8, 2023

Offering an unparalleled content-rich program capturing breakthroughs and promising discoveries impacting brain research in both health and disease

YORBA LINDA, Calif., March 2, 2023 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is excited to host its 11th annual Neuroscience event in the Neuroscience Virtual Event Series. For nearly a decade, this free online event promises to showcase cutting-edge advances in understanding the human brain, neuropsychiatric disorders, and behavioral processes as it relates to brain function.

This reputable forum not only brings together thousands of innovative researchers, clinicians, and scientists across leading medical, industry, and academic institutions from around the world, but will feature some of the brightest minds pioneering the field to explore the latest scientific findings, innovative approaches, and emerging topics. The informative and educational agenda includes sessions spanning artificial neural networks and explainable AI models at the service of neuroscience research revealed and organized by the National Institutes of Health (NIH) Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, new developments in neurodegenerative disease research, progress in mapping and targeted modulations of psychiatric disease biomarkers, and neuroscience, ethics and society: hopes and challenges.

Conference highlights at a glance include:

  • Four stellar keynote deliveries with lively Q&A attendee participation, including these distinguished presenters: Dr. Marzyeh Ghassemi, Assistant Professor, Electrical Engineering and Computer Science, Institute for Medical Engineering and Science, MIT; Dr. Marco Prado, Robarts Scientist and Professor in Physiology and Pharmacology and Anatomy & Cell Biology, The University of Western Ontario, Canada Research Chair in Neurochemistry of Dementia; Dr. Guangyu Robert Yang, Assistant Professor, Department of Brain and Cognitive Sciences, Computational Neuroscientist, Massachusetts Institute of Technology; and Dr. Timothy E. Brown, Assistant Professor, Department of Bioethics & Humanities, University of Washington School of Medicine.
  • Over eight presentations comprising topics such as artificial neural networks for neuroscience, AI with application to biomedical research, variations of network architectures in neuroscience, variations of learning problems with applications to neuroscience, and applications of artificial neural networks and explainable models will comprise the NIH BRAIN Initiative track.
  • A lively Q&A Plenary Panel discussion titled, "Challenges and Opportunities of Artificial Intelligence in Neuroscience and Explainability," moderated by Dr. Konrad Kording, a neuroscience professor at the University of Pennsylvania and leading figure in the fields of motor control, neural date methods, and computational neuroscience.
  • Panel Presentation followed by live Q&A on liquid neural networks.

Translating research results between animal models and humans is critical for the development of novel therapeutic approaches," said Dr. Marco Prado, Professor in Physiology and Pharmacology and Anatomy and Cell Biology, at The University of Western Ontario. "I have helped to develop the vision that we need to use more faithful animal models, but also relevant and automated tests to evaluate cognitive function and neurodegeneration in mice and humans. At Western University, the Mouse Translational Research Accelerator Platform (MouseTRAP) addresses this gap to facilitate translation of results to improve human health. We are excited to present our research and efforts focused on developing cognitive and imaging biomarkers for toxicity due to alpha-synuclein misfolding, which is involved in Parkinson's disease and other synucleinopathies, via Labroots' unique virtual platform and extensive reach in the scientific community."

"Neurotechnologies that record from and stimulate the brain or spinal cord are becoming more and more common, and our general fascination with these technologies is transforming into a general need for therapeutic devices," said Dr. Timothy E. Brown, Assistant Professor, Department of Bioethics & Humanities at the University of Washington School of Medicine. "It is not yet clear how these technologies will change what it means to be human — or more specifically how they'll impact our personal, social, and political lives. This year, I am excited to use Labroots' virtual platform to have a candid conversation about how neurotechnologies are built and how they'll impact the human experience."

"The BRAIN initiative is interested in the potential of artificial intelligence techniques for the advancement of biomedical research," said Mauricio Rangel-Gomez, Ph.D., Chief of the Learning and Memory Program at the National Institute of Mental Health. "At this year's Labroots Neuroscience virtual conference, the NIH BRAIN Initiative has convened a select group of scientists that are at the forefront of the artificial intelligence field and its potential applications to biomedical research." https://brainblog.nih.gov/brain-blog/nih-brain-initiative-session-discuss-artificial-intelligence-and-neuroscience-11th

Moreover, you won't want to miss a discussion sponsored by ACD, a Bio-Techne brand, on spatial mapping of pain-associated G-protein coupled receptors and biomarker localization in mouse brain using RNAscope HiPlex v2 and RNA-protein co-detection assay, with a Q&A component. Other notable speakers will discuss explainable AI with application for brain imaging and drug discovery, novel tools for drug discovery in neurodegenerative diseases, the role of Alzheimer's disease pathologies in spatial memory dysfunction, modeling mild traumatic brain injury to better understand function mechanisms, and much more.

Produced on Labroots' robust platform, this online event allows participants to connect seamlessly across all desktop and mobile devices, delivering a one-stop educational experience. The highly interactive environment includes a lobby equipped with a leaderboard and gamification, an auditorium featuring live-streaming video webcasts with live attendee chats during scheduled presentations, an exhibit hall highlighting recent contributions and connect in real-time with both booth representatives, a poster hall to explore data and engage in live chats with poster authors coupled with a poster competition giving your research a competitive edge and lastly, a networking lounge to encourage collaborations with colleagues. By participating, there is a potential to earn 1 Continuing Education credit per presentation for a maximum of 40 credits.

To learn more about the event and to register free of cost, click here. Remember to use the hashtag #LRneuro to follow the conversation and connect with other members of the global Neuroscience community!

Follow @Neuroscience_LR on Twitter and @Neuroscience.LR on Facebook to connect with our specialist Neuroscience writers and stay up to date with the latest Trending News in Neuroscience. You can now also join our Neuroscience Research, Discovery & Therapeutics professional networking group on LinkedIn!

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than article and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.